Sjogren's syndrome is a chronic systemic autoimmune disease characterized by preferential damage to the exocrine (salivary and lacrimal) glands. The main pathomechanism of this disease is autoimmune inflammation, which leads to dysfunction of the glands, resulting in dry mouth (xerostomia) and eyes (xerophthalmia). In addition, Sjogren's syndrome may be accompanied by various extraglandular manifestations, including systemic disorders, in particular, damage to the joints, lungs, kidneys, nervous system and other organs. According to research, Sjogren's syndrome is more often recorded in women over 40 years old, which makes it a topical issue in geriatrics and rheumatology.
History of the disease and interesting historical facts
Sjogren's syndrome was first described by Swedish ophthalmologist Hogo Sjogren in 1933. Initially, the disease was associated exclusively with manifestations of the lacrimal and salivary glands, but later scientific studies demonstrated that it has a systemic nature. Interestingly, in 1965, the concept of primary and secondary Sjogren's syndromes was proposed, which significantly deepened the understanding of the pathological process. Over the past decades, a lot of data has accumulated on the association of Sjogren's syndrome with other autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis.
Epidemiology
According to statistics, the prevalence of Sjogren's syndrome is from 0.2% to 3% in the general population, while among patients with autoimmune diseases this figure can reach 10%. Men are less likely to get sick than women, the ratio is approximately 1:9. Sjogren's syndrome can manifest itself both in an isolated form and as part of another autoimmune disease. It is important to note that in recent years there has been an increase in the number of cases, probably due to improved diagnosis and awareness of this disease.
Genetic predisposition to this disease
Studies show that there is a significant genetic predisposition to Sjögren's syndrome. In particular, associations have been identified with genes encoding major HLA antigens, such as HLA-DR3 and HLA-DR4. These genes are involved in antigen presentation and may influence the development of the immune response. The degree of predisposition may also depend on polygenic interactions. In addition, certain mutations in genes responsible for regulating T-cell activity may increase the risk of developing the syndrome. However, the exact mechanisms leading to the autoimmune response remain the subject of active research.
Risk factors for the development of this disease
Risk factors that contribute to the development of Sjogren's syndrome include the following:
- Age: the disease is more often observed in people over 40 years of age.
- Gender (men are much more susceptible to the disease than women).
- The presence of other autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and thyroiditis.
- Exposure to viral infections such as Epstein-Barr virus and cytomegalovirus, which can initiate autoimmune reactions.
- Environmental factors such as exposure to chemicals and other toxins, and stress factors.
- Genetic predisposition: having a family history of autoimmune diseases.
Diagnosis of this disease
Diagnosis of Sjogren's syndrome is based on a comprehensive approach and includes several key stages:
1. Main symptoms:
- Xerostomia (dry mouth)
- Xerophthalmia (dry eyes)
- Pain or difficulty swallowing
- Fatigue
- Joint pain
2. Laboratory tests:
— Determination of antibody levels: anti-SS-A (Ro) and anti-SS-B (La)
- Analysis of saliva for flow and mucus
— Assessment of the activity of the inflammatory process by the levels of C-reactive protein.
3. Radiological examinations:
— Ultrasound of the salivary glands to detect structural changes
— Magnetic resonance imaging in complex cases.
4. Other types of diagnostics:
— Schirmer test to assess the productivity of the lacrimal glands.
- Biopsy of the minor salivary gland for histopathological analysis.
5. Differential diagnosis:
— It is necessary to exclude other conditions such as lymphoma, other autoimmune diseases and infections that can cause similar symptoms.
Treatment
Treatment of Sjogren's syndrome is comprehensive and aimed at relieving symptoms, preventing complications and managing associated conditions. The main treatment areas are as follows:
1. General treatment:
- Providing adequate moisture and hydration to reduce the severity of xerostomia and xerophthalmia.
— Lifestyle: drinking enough fluids and using moisturizing drops.
2. Pharmacological treatment:
— Use of artificial saliva and eye drops to relieve dry eye syndromes.
- Immunomodulators such as corticosteroids and megestrol acetate in severe cases.
3. Surgical treatment:
— Salpingostomy for persistent narrowing of the excretory ducts of the salivary glands.
4. Other types of treatment:
— Physiotherapy and rehabilitation measures to improve joint function in the presence of arthritic manifestations.
List of medications used to treat this disease
- Pilocarpine (Salagen) - to stimulate salivation.
- Cyclosporine (Restasis) - to increase tear production.
- Corticosteroids - to reduce inflammation.
- NSAIDs (non-steroidal anti-inflammatory drugs) - to manage pain syndromes.
- Methotrexate - in severe cases, for immunosuppression.
Disease monitoring
Monitoring of Sjogren's syndrome includes regular follow-up examinations to assess symptoms and the functional state of the body. The prognosis of this disease varies depending on the individual characteristics of the patient and the presence of concomitant diseases. Complications may include infectious processes (for example, mumps), the development of lymphoma, as well as chronic diseases of other organs, which requires constant monitoring and treatment adjustments.
Age-related features of the disease
Sjogren's syndrome may present with different symptoms depending on the age group. Young people may have more pronounced xerostomia and xerophthalmia, while older patients may have more systemic manifestations of the disease. It is important to consider age-related aspects when developing a treatment plan and monitoring health status.
Questions and Answers
- What is Sjogren's syndrome?
Answer: Sjogren's syndrome is a chronic autoimmune disease that causes damage to the exocrine glands and is characterized by dry mouth and eyes. - What are the main symptoms of Sjogren's syndrome?
Answer: The main symptoms include xerostomia, xerophthalmia, joint pain and general fatigue. - How is Sjogren's syndrome diagnosed?
Answer: Diagnosis is based on clinical symptoms, laboratory tests, radiological examination and salivary gland biopsy. - What treatment is available for Sjogren's syndrome?
Answer: Treatment includes the use of artificial saliva, eye drops, immunomodulators and physical therapy to manage symptoms. - What are the main risk factors for developing Sjogren's syndrome?
Answer: Risk factors include age (more common in women over 40), the presence of other autoimmune diseases, and genetic predisposition.
